Efficacy of tocilizumab in the treatment of COVID‐19: An umbrella review
Sign Up to like & getrecommendations! Published in 2022 at "Reviews in Medical Virology"
DOI: 10.1002/rmv.2388
Abstract: Tocilizumab is an interleukin (IL)‐6 receptor inhibitor that has been proposed as a therapeutic agent for treating coronavirus disease 2019 (COVID‐19). The aim of this umbrella review was to determine the efficacy of tocilizumab in… read more here.
Keywords: review; efficacy tocilizumab; tocilizumab; umbrella review ... See more keywords
Efficacy of tocilizumab in adult H syndrome: a promising therapeutic option
Sign Up to like & getrecommendations! Published in 2021 at "International Journal of Dermatology"
DOI: 10.1111/ijd.15649
Abstract: which was clearly lacking in GA lesions. Interestingly, individual red papules ultimately became flattened and pigmented, but new papules appeared along the border of the erythematous plaques and the lesions gradually enlarged, with central hyperpigmentation.… read more here.
Keywords: adult syndrome; efficacy tocilizumab; tocilizumab adult; syndrome promising ... See more keywords
Efficacy of tocilizumab in patients with hand osteoarthritis: double blind, randomised, placebo-controlled, multicentre trial
Sign Up to like & getrecommendations! Published in 2020 at "Annals of the Rheumatic Diseases"
DOI: 10.1136/annrheumdis-2020-218547
Abstract: Objective To evaluate the efficacy of tocilizumab, an antibody against IL-6 receptor, in patients with hand osteoarthritis. Methods This was a multicentre, 12-week, randomised, double-blind, placebo-controlled study from November 2015 to October 2018. Patients with… read more here.
Keywords: patients hand; efficacy tocilizumab; hand osteoarthritis; placebo ... See more keywords